Target intelligence / Profile preview

LncKdm2b (Kdm2b divergent transcript) (KDM2B-DT)

Target
KDM2B-DT
Molecular classification
Long non-coding RNA
01

Overview

LncKdm2b (also referred to as KDM2B divergent transcript, KDM2B-DT, or Kancr) is a long non-coding RNA transcribed antisense and upstream of the KDM2B gene from a bidirectional promoter[1][3]. It is transiently expressed during the early differentiation of cortical projection neurons and acts in cis to positively regulate the expression of KDM2B by facilitating a chromatin environment favorable to transcription, partly through association with the RNA-binding protein hnRNPAB[1][3]. Both LncKdm2b and KDM2B are important for proper differentiation and migration of cortical neurons in the developing brain. Unlike classical protein-coding drug targets, LncKdm2b is not currently considered a therapeutic target but plays an important regulatory role in neurodevelopment[1][3].

Other names
LncKdm2bKancrKdm2b upstream-antisense non-coding RNAA930024E05Rik
02

Biological functions

Regulation of gene expression in cis (specifically, upregulation of KDM2B)Chromatin remodeling (facilitates a permissive chromatin state at the KDM2B promoter)Positive regulation of neuronal differentiation (especially in cortical projection neurons)
03

Disease associations

Likely involvement in neurodevelopmental disorders due to its regulatory effect on KDM2B, which has a defined role in such conditions

Beyond the preview

Go deeper on LncKdm2b (Kdm2b divergent transcript) (KDM2B-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on LncKdm2b (Kdm2b divergent transcript) (KDM2B-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call